We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Launch Pilot Program on Model-Informed Drug Development
FDA to Launch Pilot Program on Model-Informed Drug Development
The FDA announced a new pilot program in which drug sponsors can meet with agency officials to discuss strategies for model-informed drug development (MIDD) to make their clinical trials more efficient and increase the chances of regulatory approval.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor